Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26716643 | 0.85 | TDP2 (0.33) | CD44KDM4EHTTSMN1; SMN2TSHR | |
| SCHEMBL21732329 | 0.83 | KDM4E (0.40) | CD44CYP2A6CYP1A2KDM4EHTT | |
| SCHEMBL25447006 | 0.78 | SMN1; SMN2 (0.36) | CD44CYP2A6CYP1A2MYCKDM4E | |
| SCHEMBL25447081 | 0.77 | TRPA1 (0.35) | CD44CYP2A6CYP1A2MYCKDM4E | |
| SCHEMBL25447157 | 0.77 | KDM4E (0.39) | CD44CYP2A6CYP1A2KDM4EHTT | |
| SCHEMBL25445645 | 0.76 | CD44 (0.38) | CD44CYP2A6CYP1A2CA1CA2 | |
| SCHEMBL1277062 | 0.74 | — | — | |
| Water SCHEMBL22654522 | 0.72 | ACHE (0.35) | CYP2A6CYP1A2KDM4EHTTSMN1; SMN2 | |
| Iodide SCHEMBL28884004 | 0.72 | SMN1; SMN2 (0.38) | CYP2A6CYP1A2KDM4EHTTSMN1; SMN2 | |
| Bromide SCHEMBL27774766 | 0.72 | SMN1; SMN2 (0.36) | CYP2A6CYP1A2KDM4EHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240224783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240218004-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240074301-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-02-29 | — | — | US | disclosed |
| EP-4329463-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4001287-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2024-01-17 | — | — | EP | disclosed |
| US-11864458-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-01-02 | — | — | US | disclosed |
| US-11839141-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-12-05 | — | — | US | disclosed |
| EP-3858945-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11827651-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230365606-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230151039-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230157154-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-18 | — | — | US | disclosed |
| EP-3771717-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-05-17 | — | — | EP | disclosed |
| US-20230143449-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230142498-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230147066-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230146148-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-11 | — | — | US | disclosed |
| US-11647667-B2 | Organic electroluminescent compounds and organic light emitting devices using the same | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-09 | — | — | US | disclosed |
| US-11639363-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-02 | — | — | US | disclosed |
| US-20230130017-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157154-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, SOD1, GLRA3 | CD44 1539/4885CYP2A6 4469/4885CYP1A2 2593/4885 |
| US-20230146148-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ICOSLG | CD44 3319/4885CYP2A6 1340/4885CYP1A2 378/4885 |
| US-11647667-B2 | Organic electroluminescent compounds and organic light emitting devices using the same | OCIAD1, OCIAD2, ODC1 | CD44 4509/4885CYP2A6 1474/4885CYP1A2 421/4885 |
| US-20230130017-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, SSB | CD44 1316/4885CYP2A6 2419/4885CYP1A2 872/4885 |
| US-11839141-B2 | Organic electroluminescent materials and devices | OSBP, OCIAD1, OCIAD2 | CD44 4166/4885CYP2A6 1634/4885CYP1A2 471/4885 |
| US-11864458-B2 | Organic electroluminescent materials and devices | RAP1A, L1CAM, SOD1 | CD44 369/4885CYP2A6 3709/4885CYP1A2 1602/4885 |
| US-20230147066-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, SSB, MCOLN3 | CD44 3348/4885CYP2A6 3903/4885CYP1A2 2263/4885 |
| US-20230143449-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OXER1 | CD44 3881/4885CYP2A6 2060/4885CYP1A2 605/4885 |
| US-20230142498-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, LEF1 | CD44 3632/4885CYP2A6 2543/4885CYP1A2 723/4885 |
| US-20240074301-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, OCIAD2, OSBP | CD44 1116/4885CYP2A6 3207/4885CYP1A2 1152/4885 |
| US-20240224783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | CD44 2270/4885CYP2A6 1979/4885CYP1A2 525/4885 |
| US-11639363-B2 | Organic electroluminescent materials and devices | LEF1, L1CAM, SSB | CD44 390/4885CYP2A6 3346/4885CYP1A2 1997/4885 |
| US-20230365606-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, OPRD1, OXSR1 | CD44 2362/4885CYP2A6 3224/4885CYP1A2 1009/4885 |
| US-11827651-B2 | Organic electroluminescent materials and devices | SSB, L1CAM, LEF1 | CD44 32/4885CYP2A6 4187/4885CYP1A2 3297/4885 |
| US-20230151039-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RPS4X, SOD1, CNKSR1 | CD44 1302/4885CYP2A6 3655/4885CYP1A2 2537/4885 |
| US-20240218004-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, CCND2 | CD44 2506/4885CYP2A6 3970/4885CYP1A2 1065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.